Directory
>
Jennifer Buell
Jennifer Buell
Director Board of Directors | Agenus
Dover, Massachusetts, United States
Jennifer Buell
Summary
Jennifer Buell is a seasoned executive in the biotechnology sector, currently serving as the President and CEO of MiNK Therapeutics. With a robust background in biochemistry and clinical development, she has a proven track record in leading innovative drug discovery and development initiatives. Her leadership experience spans various high-profile roles at Agenus, where she significantly contributed to the company's strategic direction as both President and Chief Operating Officer. Jennifer's expertise in immunology and oncology, combined with her academic credentials from Tufts University School of Medicine, positions her as a thought leader in her field. She is passionate about advancing research in life sciences and is actively involved in clinical trials and program management. In addition to her executive roles, she has published extensively on the intersection of vitamin D and cognitive health, showcasing her commitment to integrating scientific research into practical applications.
Jennifer Buell
Work Experience
Director Board of Directors at
Agenus
June 2024 - Present
Chairman, Executive Counsel Agenus at
Agenus
January 2023 - Present
President and Chief Executive Officer at
Mink Therapeutics, Inc.
October 2021 - Present
President and Chief Operating Officer at
Agenus
November 2018 - January 2023
Chief External Affairs Officer at
Agenus
November 2017 - November 2018
Vice President Research and External Affairs at
Agenus
July 2016 - March 2018
Vice President Research and Development Operations and Program Management at
Agenus
September 2013 - August 2016
Senior Director Clinical Program Management, External Collaborations, and EQOL at
Harvard Clinical Research Institute
December 2010 - September 2013
Director of Clinical Program Management at
Agenus
September 2006 - December 2010
NIH Visiting Scholar Program at
The National Institutes of Health
January 2008 - December 2008
Operations Lead/Sr. Clinical Program Lead at
i3 Research
January 2001 - January 2004
Neurology Lead/Clinical Program Leader at
Worldwide Clinical Trials Early Phase Services, Llc.
January 1999 - January 2002
Clinical Development - MRA/Program Lead at
Bristol Myers Squibb
January 1995 - January 1999
Jennifer Buell
Education
Tufts University School of Medicine, Phd
January 2001 - January 2007
Frequently Asked Questions about Jennifer Buell
What is Jennifer Buell email address?
Jennifer Buell's primary email address is **************@agentustherapeutics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Jennifer Buell work for?
Jennifer Buell is a Director Board of Directors at Agenus, a company specializing in Commercial physical research.
Where Jennifer Buell graduated from?
Jennifer Buell holds a degree in Cellular, Biochemical And Molecular Metabolism from Tufts University School of Medicine.
How can I directly contact Jennifer Buell?
To contact Jennifer Buell directly, you can use the email address **************@agentustherapeutics.com. Complete contact information is available upon registration with Muraena.
Who is Jennifer Buell?
Jennifer Buell is a seasoned executive in the biotechnology sector, currently serving as the President and CEO of MiNK Therapeutics. With a robust background in biochemistry and clinical development, she has a proven track record in leading innovative drug discovery and development initiatives. Her leadership experience spans various high-profile roles at Agenus, where she significantly contributed to the company's strategic direction as both President and Chief Operating Officer. Jennifer's expertise in immunology and oncology, combined with her academic credentials from Tufts University School of Medicine, positions her as a thought leader in her field. She is passionate about advancing research in life sciences and is actively involved in clinical trials and program management. In addition to her executive roles, she has published extensively on the intersection of vitamin D and cognitive health, showcasing her commitment to integrating scientific research into practical applications.
Jennifer`s contact details
**************@agentustherapeutics.com
**************@agenusbio.com
Colleagues
Independent board member
Chief Commercial Officer
Vice President, Commercial Operations and Business Analytics
Vice President, Technical Operations
Chief Medical Officer
Chief Quality Officer
Executive Director, Global Financial Operations
Chief Commercial Transactions Officer
Associate Vice President, Head of Global HEOR Medical Value Access
VP Molecular and Information Science